Chad Gassert - 22 Jun 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship: SVP - CORP. DEV. & STRATEGY
Issuer ticker: ANIP
Reported as of: 22 Jun 2023
Net transaction value: -$1,026,400
SEC form: 4
Accepted by SEC: 23 Jun 2023, 20:00:34 UTC
Prior SEC filing: 04 Apr 2023
Next SEC filing: 06 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Chad Gassert, by attorney-in-fact Meredith W. Cook

Key filing fact

Chad Gassert filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 23 Jun 2023.

Key facts

This page summarizes Chad Gassert's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Jun 2023, 20:00.

Change

Previous filing in this sequence was filed on 04 Apr 2023.
Current net transaction value: -$1,026,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Sale

Transaction value: $1,026,400
Shares: -20,000
Change %: -5.1%
Price: $51.32
Shares after: 373,226
Date: 22 Jun 2023
Ownership: Held by Chali Properties LLC
Footnotes: F1, F2

ANIP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 28,947
Date: 22 Jun 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.

Footnote F2

The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.